The New York Times sports an age-old and notable credo with “all the news that’s fit to print.” If there’s an unofficial motto that Outpatient Care Technology magazine can adopt it’s this: All the news we can fit in print.
You may have noticed within the last year a small box that tends to show up at the end of some of our longer features, titled, “Continued online: Due to space constraints this article is continued at www.OPCTonline.net.”

It’s no secret that the bariatric patient population poses considerable challenges to the healthcare provider, particularly in the outpatient segment, and to the healthcare product manufacturer. One has to prepare its facilities to accommodate the patients; the other has to make products that facilitate such preparation.

The incidence of obesity and its related co-morbidities are increasingly becoming more visible. Primary pathologies, such as high blood pressure, elevated blood sugar, abnormal cholesterol levels, and secondary conditions such as sores, ulcers, arthritis, chronic pain, sleep disorders and depression all can be traced to rising incidences of obesity.
The climbing prevalence of these conditions is placing a significant strain on the healthcare system. Recent estimates show the cost of obesity-linked illnesses to the Medicare and Medicaid programs in the U.S. is over $40 billion.

Delivering a concentrated dose of radiation to a specific anatomical target that typically moves tends to be a hit-and-miss proposition without the proper tools.

Pre-operative sampling of suspicious lymph nodes in the axilla has historically been very difficult. This area is highly vascular and many physicians do not feel comfortable acquiring tissue in this region. Fine needle aspiration under ultrasound-guidance is one method for acquiring tissue in the axilla; however this method is heavily dependent on the physician’s technique and level of experience. Current spring-loaded core devices on the market are not practical for use in the axilla, as the true depth post-fire is unknown.

Until a year ago, I was treating biopsy-proven fibroadenomas by either observation or surgical excision. While I find surgical excision effective, the drawbacks include the need for general anesthesia, increased patient stress, recovery time, and based on fibroadenoma size — scarring and potential disfigurement. Observation can also be stressful on patients, especially when their fibroademomas are larger than 1 centimeter.


Quick communication between medical staff is often critical in acuity care, and new technologies are helping make it easier for staffs to increase speed and efficiency. Staffs no longer need to depend on intercom pages, pagers, landline phones or cell phones.

December 18, 2007 – ProSolv CardioVascular, a Fujifilm company, announced that they have been ranked No. 1 by KLAS in the 2007 Cardiology PACS Study, achieving the highest total score when evaluated on 40 performance indicators, ranking first in 26 of the 40 indicators.

Advanced Radiation’s AccuBoost system is designed to deliver focused radiation to the lumpectomy cavity following either whole breast irradiation (WBI) or as a monotherapy for accelerated partial breast irradiation (APBI) treatment.

GE Healthcare announced that it has received FDA approval for its new mobile mammography product, Senographe Essential, designed to improve access to breast cancer screening.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now